These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1524206)

  • 1. Quantification of desferrioxamine and its iron chelating metabolites by high-performance liquid chromatography and simultaneous ultraviolet-visible/radioactive detection.
    Singh S; Mohammed N; Ackerman R; Porter JB; Hider RC
    Anal Biochem; 1992 May; 203(1):116-20. PubMed ID: 1524206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of desferrioxamine-available iron in biological tissues by high-pressure liquid chromatography.
    Gower JD; Healing G; Green CJ
    Anal Biochem; 1989 Jul; 180(1):126-30. PubMed ID: 2817334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validated HPLC assay for iron determination in biological matrices based on ferrioxamine formation.
    Tesoro A; Novakovic J; Thiessen JJ; Spino M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):177-83. PubMed ID: 16023418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nanocellulose-based colorimetric assay kit for smartphone sensing of iron and iron-chelating deferoxamine drug in biofluids.
    Faham S; Golmohammadi H; Ghavami R; Khayatian G
    Anal Chim Acta; 2019 Dec; 1087():104-112. PubMed ID: 31585557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of desferrioxamine, ferrioxamine and aluminoxamine by post-column derivatization high-performance liquid chromatography. Non-linear calibration resulting from second-order reaction kinetics.
    Kraemer HJ; Breithaupt H
    J Chromatogr B Biomed Sci Appl; 1998 Jun; 710(1-2):191-204. PubMed ID: 9686887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation and identification of desferrioxamine and its iron chelating metabolites by high-performance liquid chromatography and fast atom bombardment mass spectrometry: choice of complexing agent and application to biological fluids.
    Singh S; Hider RC; Porter JB
    Anal Biochem; 1990 Jun; 187(2):212-9. PubMed ID: 2116739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability to determine the desferrioxamine-chelatable iron fractions of nontransferrin-bound iron using HPLC.
    Koba M; Słomka A; Bączek T; Marszałł MP; Zekanowska E
    J Sep Sci; 2013 Feb; 36(4):665-9. PubMed ID: 23355397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.
    Lee P; Mohammed N; Marshall L; Abeysinghe RD; Hider RC; Porter JB; Singh S
    Drug Metab Dispos; 1993; 21(4):640-4. PubMed ID: 8104123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The determination of ferric iron in plants by HPLC using the microbial iron chelator desferrioxamine E.
    Fernández V; Winkelmann G
    Biometals; 2005 Feb; 18(1):53-62. PubMed ID: 15865410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A direct method for quantification of non-transferrin-bound iron.
    Singh S; Hider RC; Porter JB
    Anal Biochem; 1990 May; 186(2):320-3. PubMed ID: 2363505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low percentage of aluminoxamine and ferrioxamine in uremic serum after desferrioxamine administration.
    Menéndez-Fraga P; Fernández-Martín JL; Blanco-González E; Cannata-Andía JB
    Clin Chem; 1998 Jun; 44(6 Pt 1):1262-8. PubMed ID: 9625051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatography of deferoxamine and ferrioxamine: interference by iron present in the chromatographic system.
    Cramer SM; Nathanael B; Horváth C
    J Chromatogr; 1984 Jul; 295(2):405-11. PubMed ID: 6432830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversed-phase high-performance liquid chromatography of non-transferrin-bound iron and some hydroxypyridone and hydroxypyrone chelators.
    el-Jammal A; Templeton DM
    J Chromatogr B Biomed Appl; 1994 Aug; 658(1):121-7. PubMed ID: 7952112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of iron(III) chelate separated by reversed-phase high-performance liquid chromatography.
    Wang YM; Cheng TH
    Kaohsiung J Med Sci; 1996 May; 12(5):267-73. PubMed ID: 8676431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of desferoxamine and a major metabolite by high-performance liquid chromatography. Application to the treatment of aluminium-related disorders.
    Kruck TP; Kalow W; McLachlan DR
    J Chromatogr; 1985 May; 341(1):123-30. PubMed ID: 4019677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect micro-scale method for the determination of desferrioxamine and its aluminium and iron chelated forms in biological samples by atomic absorption spectrometry with electrothermal atomisation.
    Allain P; Mauras Y; Beaudeau G; Hingouet P
    Analyst; 1986 May; 111(5):531-3. PubMed ID: 3740423
    [No Abstract]   [Full Text] [Related]  

  • 17. High-performance liquid chromatographic analysis of desferrioxamine. Pharmacokinetic and metabolic studies.
    Kruck TP; Teichert-Kuliszewska K; Fisher E; Kalow W; McLachlan DR
    J Chromatogr; 1988 Dec; 433():207-16. PubMed ID: 3235548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-performance liquid chromatographic method for the measurement of deferoxamine in body fluids.
    Tesoro A; Leeder JS; Bentur Y; Klein J; Freedman M; Koren G
    Ther Drug Monit; 1989; 11(4):463-70. PubMed ID: 2741196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferrioxamine and its hexadentate iron-chelating metabolites in human post-desferal urine studied by high-performance liquid chromatography and fast atom bombardment mass spectrometry.
    Lehmann WD; Heinrich HC
    Anal Biochem; 1990 Feb; 184(2):219-27. PubMed ID: 2109548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an intravenous desferrioxamine mesylate treatment protocol for swine: monitoring of desferrioxamine and metabolites by high-performance liquid chromatography.
    Fisher EA; McLachlan DR; Kruck TP; Mustard RA
    Pharmacology; 1990; 41(5):263-71. PubMed ID: 2092330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.